Elevance Health (NYSE: ELV) Q4 2024 Earnings Call Jan 23, 2025, 8:30 a.m. ET ...

Financial writer recommends buying Elevance Health stock despite recent drop, citing strong industry trends and potential for ...

Investment management company Vulcan Value Partners recently released its fourth-quarter 2024 investor letter. A copy of the ...

Centene (CNC) stock and Molina Healthcare (MOH) stock were among notable gainers after a Q4 revenue beat from their Medicaid peer, Elevance Health (ELV). Read more here.

Elevance Health Inc. (ELV), while reporting weak fourth-quarter earnings below market estimates, on Thursday issued fiscal 2025 ...

The company posted adjusted earnings per share of $3.84 for Q4 2024, falling short of the $3.98 consensus estimate. Revenue ...

Elevance Health posted $418 million in profit for the fourth quarter of 2024, a figure that surpassed Wall Street's ...

Elevance Health Q4 revenues hit $45 billion, driven by premium growth and acquisitions. 2025 EPS guidance is $34.15-$34.85, with a $1.71 dividend declared.

Major healthcare plan provider UnitedHealth Group Incorporated UNH reported strong fourth-quarter earnings last week, primarily driven by growth in domestic commercial membership and Medicare ...

The stock market rebounded to or above key levels on tame inflation data and strong bank earnings. Many stocks flashed buy ...

Elevance Health Inc. (ELV) released a profit for fourth quarter that decreased from last year The company's bottom line totaled $418 ...

For the year, the company reported profit of $5.98 billion, or $25.68 per share. Revenue was reported as $175.2 billion. Elevance Health expects full-year earnings in the range of $34.15 to $34.85 per ...